A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort-Reference-Cited by-同舟云学术

A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort

Published:2014-05-27 Issue:6 Volume:66 Page:1472-1481
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Gross Rachael L.¹,Schwartzman-Morris Julie S.¹,Krathen Michael²,Reed George³,Chang Hong²,Saunders Katherine C.⁴,Fisher Mark C.⁵,Greenberg Jeffrey D.⁶,Putterman Chaim¹,Mease Philip J.⁷,Gottlieb Alice B.²,Kremer Joel M.⁸,Broder Anna¹

Affiliation:

1. Albert Einstein College of Medicine; Bronx, New York

2. Tufts Medical Center; Boston, Massachusetts

3. University of Massachusetts School of Medicine; Worcester

4. CORRONA, Inc.; Boston, Massachusetts

5. NYU Hospital for Joint Diseases; New York

6. New York University School of Medicine and NYU Hospital for Joint Diseases; New York

7. Seattle Rheumatology Associates; Seattle, Washington

8. Albany Medical College; Albany, New York

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38385/fullpdf

Reference47 articles.

1. The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan;Chen;Arthritis Rheum,2011

2. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland;Hakulinen;Am J Med,1985

3. Rheumatoid arthritis and cancer risk;Mellemkjaer;Eur J Cancer,1996

4. Risk of malignancy among patients with rheumatic conditions;Thomas;Int J Cancer,2000

5. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden;Boffetta;J Invest Dermatol,2001

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial;Arthritis Research & Therapy;2024-07-29

2. Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study;RMD Open;2024-07

3. Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data;Rheumatology and Therapy;2024-05-02

4. Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study;RMD Open;2024-05

5. Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials;Arthritis Research & Therapy;2024-02-12